CHINARES PHARMA (03320): KPC Pharmaceuticals, Inc. reported a net loss attributable to shareholders of 364 million yuan in the first half of the year, turning from profit to loss compared to the same period last year.

19:19 21/08/2026

China Resources Pharmaceutical (03320) announced that its subsidiary Kunming Pharmaceutical Group achieved total operating revenue of 1.643 billion yuan for the six months ending June 30, 2026, a decrease of 50.97% year-on-year; the net loss attributable to shareholders of the listed company was 364 million yuan, compared to a net profit of 198 million yuan in the same period last year; the basic loss per share was 0.48 yuan.

CHINARES PHARMA (03320) announced that its subsidiary KPC Pharmaceuticals, Inc. achieved total operating revenue of 1.643 billion yuan for the six months ending June 30, 2026, a year-on-year decrease of 50.97%; the net loss attributable to shareholders of the listed company was 364 million yuan, compared to a net profit of 198 million yuan in the same period last year; the basic loss per share was 0.48 yuan.

EAST BUY (01797) announced its annual results, reporting an adjusted profit of approximately 629 million yuan, a year-on-year increase of 262.2%.

Fibocom Wireless Inc. (00638) increased its capital in its holding subsidiary Shanghai Guangyi through a debt-to-equity swap, terminated its equity incentive plan, and sold its equity.

CHINA ALUMCAN (06898) will distribute a mid-term dividend of HKD 0.002 per share on October 28.

EAST BUY (01797) announced its annual results, reporting an adjusted profit of approximately 629 million yuan, a year-on-year increase of 262.2%.

Fibocom Wireless Inc. (00638) increased its capital in its holding subsidiary Shanghai Guangyi through a debt-to-equity swap, terminated its equity incentive plan, and sold its equity.

CHINA ALUMCAN (06898) will distribute a mid-term dividend of HKD 0.002 per share on October 28.